CVE-2023-39537

Improper input validation in BIOS TCG2

Description

AMI AptioV contains a vulnerability in BIOS where an Attacker may use an improper input validation via the local network. A successful exploit of this vulnerability may lead to a loss of confidentiality, integrity and availability.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.07%
Vendor Advisory hubspotusercontent-na1.net
Affected: AMI AptioV
Published at:
Updated at:

References

Link Tags
https://9443417.fs1.hubspotusercontent-na1.net/hubfs/9443417/Security%20Advisories/AMI-SA-2023008.pdf vendor advisory

Frequently Asked Questions

What is the severity of CVE-2023-39537?
CVE-2023-39537 has been scored as a high severity vulnerability.
How to fix CVE-2023-39537?
To fix CVE-2023-39537, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-39537 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-39537 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-39537?
CVE-2023-39537 affects AMI AptioV.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.